ArticleProceedings of the National Academy of Sciences of the United States of America2026
B cells enable autoreactive T cells to avoid suppression.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Clinical trials and experimental observations have shown that B cells are essential for development of T cell-mediated organ-specific autoimmunity, although their exact contribution is not clear. As antigen presentation by B cells is focused on antigens cognate to their antigen receptors, we reasoned that B cells would facilitate activation of T effector cells (Teff) with the same antigen specificity but would poorly activate regulatory T cells (Treg) due to insufficient presence of antigen-specific Tregs among polyclonal/multispecific Tregs at the early stages of pathogenesis. At the same time, activation of Teff by autoantigens presented by dendritic cells (DC) would be sensitive to by-stander suppression by Tregs as DCs express a variety of antigenic peptides. We used Teff cells (KRN) and B cells (121) reactive to the same antigen - glucose-6-phosphate-isomerase (GPI) to show that KRN T cells activation was sensitive to polyclonal Tregs only when activated by DCs but not by B cells. However, as expected, GPI-specific Tregs were fully capable of suppressing Teff activation by B cells. Our findings shed light on the role of B cells in organ-specific autoimmunity and provide knowledge-based support for application of anti-B cell immunotherapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.